Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium in adult asthmatics with acid reflux
NCT00628953Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Esomeprazole Arm with Placebo Arm (2 arms). Primary endpoints: Peak Expiratory Flow (morning) at 16 weeks, Peak Expiratory Flow (evening) at 16 weeks and 2 more. Started Oct 2002; status: completed.
02
Drugs
esomeprazole
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00628953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628953.